Original language | English |
---|---|
Journal | British Journal of Haematology |
DOIs | |
Publication status | Accepted/In press - 2021 |
Gemtuzumab ozogamicin in (KMT2A)-rearranged adult acute myeloid leukaemia (AML) in the UK Medical Research Council AML15 and AML16 trials
Richard Dillon, Robert K. Hills, Alan K. Burnett, Nigel H. Russell*
*Corresponding author for this work
Research output: Contribution to journal › Letter › peer-review
4
Citations
(Scopus)